The Stockholm Stock Exchange traded down on a report-intensive Tuesday session. Market rates rose a few more points. Among the reporting companies, Saab rose sharply while Munters fell heavily.

At the close, the OMXS30 index was down 0.18 percent to 2,571.51. Shares worth around SEK 19.7 billion were traded on the Stockholm Stock Exchange.

The best performance among the exchange's major industrial sectors was in commodities with a rise of 0.8 percent. At the other end of the scale, healthcare was at the bottom with minus 1.3 percent.

Among the leading stocks, which are included in the OMXS30 index, Saab rose 8.9 percent while Boliden was up 1.7 percent. Tele 2 was the worst performer, down 2.6 percent, while Nibe was down 1.7 percent.

Mining company Boliden's adjusted operating profit came in above expectations in the third quarter and amounted to SEK 2,999 million. According to Bloomberg, expectations were 2,291 million. Sales were also better than expected. The share rose 1.7 percent.

Vehicle manufacturer Traton released a reverse earnings warning, announcing that operating profit and cash flow for the third quarter will "significantly exceed" market expectations. Operating profit is expected to be €1,140 million (955), compared to the 1,026 expected according to analyst consensus from the company. The outlook was reiterated. The share rose 2.6 percent.

The telecom operator Tele2 presented an interim report that was in line with expectations. Underlying EBITDA amounted to SEK 2,818 million (2,781 the year before). The expectation was SEK 2,842 million. The full-year and medium-term outlook was reiterated. The share fell 2.6 percent.

Defense company Saab's operating profit was slightly better than expected in the third quarter and amounted to SEK 1,187 million. Order intake rose 41 percent. The company reiterated its forecast for organic sales growth for the full year 2024 of 15-20 percent, but at the upper end of the range. CEO Micael Johansson also stated that a process had begun to negotiate the contract for Gripen sales to Thailand. The share rose 8.9 percent.

The climate control company Munters' adjusted ebita earnings came in line with expectations at SEK 611 million. At the same time, order intake was significantly weaker than expected. The share fell 11 percent.

The industrial conglomerate Lifco's adjusted ebita earnings came in line with expectations at SEK 1,398 million. The share fell 5.8 percent.

The research-based pharmaceutical company Camurus has received a Complete Response Letter (CRL), i.e. a request for additional information from the US Food and Drug Administration (FDA) regarding the application for marketing authorization for CAM2029 for the treatment of acromegaly. The share fell 9.8 percent.

Getinge's principal owner Carl Bennet buys shares in the company for just over SEK 91 million. The share rose 1.1 percent.

On the analysis front, ABG lowered the recommendation on Cint to hold from buy. The share went down 3.1 percent.

BNP Paribas lowered Alimak to neutral from outperform. The share fell 1.9 percent.